Biovotion Selected as Finalist in $2.25 Million Nokia Sensing XCHALLENGE

The final phase of the Nokia Sensing XCHALLENGE includes an online voting campaign accounting for 10% of a team’s overall score, with the remainder evaluated by a judging panel comprised of digital health and medical industry experts. Videos of the finalist teams and their breakthrough technologies can be viewed and voted on beginning today through October 30 at www.nokiasensingxchallengevoting.org. The winning teams will be announced on November 10, 2014. This is the second of two consecutive, separate competitions in the Nokia Sensing XCHALLENGE.

Biovotion AG is a Swiss medical device and digital health company, developing a wearable, medical-grade vital sign monitoring platform – ‘hospital on the arm’. The platform consists of a comfortably wearable, easy-to-use device, cloud-based services and applications with advanced user interfaces. The company has industry-leading expertise and holds intellectual property in the field of biosensors, algorithm development and the transformation of data into relevant medical feedback, also known as “actionable information.” The team’s established experience   has been integral in the platform’s development path of medical-grade vital sign monitoring to hydration and glucose monitoring. The platform is able to deliver medical-grade data quality under motion and in everyday life. This allows it to serve applications in both the medical field, as well as general consumer monitoring.

About XPRIZE
Founded in 1995, XPRIZE is the leading organization solving the world’s Grand Challenges by creating and managing large-scale, high-profile, incentivized prizes in five areas: Learning; Exploration; Energy & Environment; Global Development; and Life Sciences. Active prizes include the $30M Google Lunar XPRIZE, the $15M Global Learning XPRIZE, the $10M Qualcomm Tricorder XPRIZE, the $2.25M Nokia Sensing XCHALLENGE and the $2M Wendy Schmidt Ocean Health XPRIZE. For more information, visit www.xprize.org